One hundred years after the heroic journey to Nome, scientists reveal how Balto's DNA explains his incredible endurance and ...
The biotech’s phase 3 delivered the hoped-for second biomarker hit, reporting an 82% decline in serum creatine kinase after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback